Christiane Amanpour's Ovarian Cancer and the Importance of Early Detection Renowned reporter calls on women to advocate for themselves Oct 11, 2021
Ibrutinib-Rituximab Wins Out in Waldenstrom's Macroglobulinemia Risk of disease progression or death reduced by 75% versus rituximab alone Oct 11, 2021
Case: VEGFR Inhibition in Merkel Cell Carcinoma Patient Disease stabilized after post-chemotherapy progression of the aggressive neuroendocrine cancer Oct 11, 2021
What's the Best Way to Treat Femur Breaks From Bone Metastases? No difference in outcomes between long-stem hemiarthroplasty and intramedullary nailing Oct 10, 2021
Pediatric Sarcoma Patients Face Late Amputation Risk Decades Later Study finds about 18% required amputation long after initial limb salvage surgery Oct 09, 2021
Take Sarcoma Research Based on Registry Data With a Grain of Salt Many studies using SEER/NCDB registries often generated disparate outcomes Oct 08, 2021
No Benefit for Longer-Duration Antibiotic Prophylaxis After Limb Salvage Surgical site infections similar versus shorter-duration prophylactic IV regimen Oct 08, 2021
Antibiotic Could Thwart Costly Sarcoma Surgery Complication Benefit seen for adding "anaerobic coverage" to standard perioperative antibiotic prophylaxis Oct 07, 2021
Standard of Care Hard to Beat in HER2-Negative Breast Cancer Swapping letrozole for fulvestrant, in combination with palbociclib, did not improve PFS Oct 07, 2021
Can the Death Rattle Be Silenced? Randomized trial says yes, but results may be challenging to put into practice Oct 05, 2021
Women With Very Dense Breasts Benefit From MRI Screening Dutch researchers recommend screening with MRI every 4 years Oct 01, 2021
The Cost of Blood Platelets Is About to Surge FDA's flawed new guidance for blood transfusion safety takes effect October 1 Sep 30, 2021
Different Taxanes, Similar Outcomes in Advanced HER2-Positive Breast Cancer Results from docetaxel-based study appear applicable to paclitaxel, nab-paclitaxel Sep 29, 2021
Immunotherapy Combo Fails to Boost Survival in Limited-Disease SCLC No PFS or OS improvement with consolidation nivolumab-ipilimumab after standard treatment Sep 29, 2021
Improved DFS, but No OS Boost, With Chemo in CRC With Liver Metastases Longer disease-free survival did not mean longer overall survival for these patients Sep 28, 2021
What's Behind the Racial Differences in Women's Cancer Screening? Existing medical conditions and social factors are likely driving gaps, researchers found Sep 24, 2021
FDA Issues Orders Clarifying Rules for Marketing Sunscreens But more studies on sunscreen chemicals are still needed, advocacy group says Sep 24, 2021
Another Checkpoint Inhibitor Misses Mark in Ovarian Cancer No OS or PFS benefit with nivolumab versus chemotherapy for platinum-resistant disease Sep 24, 2021
Radiation or Surgery in Early Lung Cancer: Does It Make a Difference? Ablative radiation still noninferior to VATS after longer follow-up Sep 24, 2021
How Many Deaths Will New Cigarette Warnings Prevent? Modeling study comes up with big numbers Sep 24, 2021
Fully Automated Capsule Endoscopy Feasible for Gastric Exams Minimally invasive, magnetically controlled capsule comparable to conventional endoscopy Sep 23, 2021
Checkpoint Inhibitors Whiff in Head and Neck Cancer Trials Avelumab, nivolumab-ipilimumab, pembrolizumab miss endpoints in separate studies Sep 23, 2021
Top Science From the World Conference on Lung Cancer In this podcast, we examine some of the most important studies presented at this year's meeting Sep 23, 2021 podcast
In RA, Little Risk for Recurrent Cancer With Biologic Treatment Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
Study Finds More Later-Stage CRC Diagnoses During Pandemic Japanese registry data reveals increase in stage III colorectal cancer, drops in earlier disease Sep 22, 2021
Survey Says: Support Is Lacking for Cancer's Lingering Effects Survivors report dissatisfaction with long-term support Sep 22, 2021
Angiogenesis Inhibitor Slows Extrapancreatic Neuroendocrine Tumors Almost 7-month increase in median PFS with addition of axitinib to endocrine therapy Sep 21, 2021
Transarterial Radioembolization Slows Progression of CRC With Liver Mets Small increase in median PFS when combined with second-line chemotherapy Sep 21, 2021
Androgen-Targeting Combos Show Promise in Prostate Cancer Trials extend survival in hormone-sensitive disease Sep 21, 2021
Bifunctional Protein Shows Promise in HPV-Related Cancers Objective responses in 28% of pretreated patients, durable in most cases Sep 20, 2021
Sunitinib Effective in Very Rare Neuroendocrine Tumor The TKI boosted PFS in patients with malignant pheochromocytoma and paraganglioma Sep 20, 2021
Chemo Plus Keytruda Boosts Overall Survival in Advanced TNBC KEYNOTE-355 regimen offers "transformative treatment" in PD-L1-positive disease, expert says Sep 20, 2021
ADC Makes a Case for Role in Metastatic HER2-Positive Breast Cancer Improved progression-free survival in previously treated disease with trastuzumab duocarmazine Sep 20, 2021
Combo Treatment Extends Survival in HR+HER2- Advanced Breast Cancer MONALEESA-2's "big message": 12.5-month boost in median OS with ribociclib-aromatase inhibitor Sep 19, 2021
Another Possible Option for HER2-Mutated Non-Small Cell Lung Cancer More than half of patients responded to antibody-drug conjugate targeting HER2 Sep 19, 2021
Adjuvant Pembrolizumab Boosts Recurrence-Free Survival in High-Risk Melanoma Also, fewer cases of distant recurrences in KEYNOTE-716 trial Sep 19, 2021
Practice-Changing Study in Advanced Cervical Cancer Improved PFS, OS with pembrolizumab and chemo with or without bevacizumab Sep 18, 2021
Trastuzumab Deruxtecan: New Standard of Care in Pretreated, Advanced Breast Cancer? DESTINY-Breast03 turns in "absolutely startling" PFS in HER2-positive metastatic disease Sep 18, 2021
Extended Letrozole Reduced Recurrence Risk in Postmenopausal Breast Cancer 5 years of the aromatase inhibitor improved disease-free survival vs 2-3 years Sep 17, 2021
